Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:

• LGP will now be able to produce medicinal cannabis flower products

• LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer
• strong supply reliability for patients

The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.

Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.

The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.